Companies who raised drug prices higher than the rate of inflation must rebate the difference to Medicare, according to a provision of the Inflation Reduction Act. The highest-profile product on the list might be AbbVie’s blockbuster immunology drug Humira.
New Covid-19 vaccine booster shots are coming and they’ll include protection against the omicron variant. The U.S. government agreed to a purchasing contract covering 105 million doses of the Pfizer/BioNTech vaccine for a planned vaccination campaign in the fall.
Transitioning to PDPM models significantly shifted the healthcare industry. By replacing the RUG system, healthcare providers cut waste and more accurately reflect the care each patient received.
Hoping to get the most out of data on social determinants, a report recommends a unified strategy led by HHS.
Transparency in pricing negotiations is key to ensuring costs are brought down, experts say, pointing to state-level legislation to mandate it.
"He will first and foremost look at how public policy will affect the practice of medicine," said Julius W. Hobson, a former American Medical Association lobbyist who has known Price since 1994.
Craig Holman, government affairs lobbyist with Public Citizen, described Price’s volume of stock trades during the SEC inquiry as “brazen,” given the congressman’s access to nonpublic information affecting the companies’ fortunes.
Every wellness clinic is only as successful as the capabilities of its software. Here's where you can find the top-rated practice management solutions for med spas.
Senate Finance Committee Chairman Sen. Orrin Hatch (R-Utah) suspended rules requiring a quorum for a vote, allowing Price to advance to the full Senate.
The Senate Democrats have been asking for more time to look into questions that he may have misled the public about issues in his financial background.
@AltHHS describes itself as "Unofficial and unaffiliated resistance account by concerned scientists for humanity."
Senate Finance Committee ranking member Ron Wyden (D-Oregon) was rather relentless in questioning Price.
Patient expectations continue to evolve, and healthcare practices that fail to adapt risk more than just revenue—they risk losing trust.
Price has been a go-to congressman, a review of his records show, for medical special interests hotly sparring with regulators or facing budget cuts.
Prospective HHS Secretary Tom Price brings a distinctive to-do list to the agency. And, if confirmed by the Senate, he will have tremendous independent power to get things done.
You got the expected praise from the right and outrage from the left, particularly for Price, who is as conservative as they get in Congress. But for the most part, the healthcare industry welcomed the picks.
Price, an orthopedic surgeon from a heavily conservative district outside Atlanta, is a staunch ACA critic and is one of the few Republicans to have a plan to replace President Obama's signature law.
The OIG report describes a range of rip-offs, some of which involve caretakers caught up in the nation’s opioid epidemic.